Authors:
ROBAK T
GORATYBOR J
URBANSKARYS H
KRYKOWSKI E
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE), MITOXANTRONE AND DEXAMETHASONE (CMD) PROGRAM IN THE TREATMENT OF REFRACTORY AND RECURRENT LOW-GRADE NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 244-244
Authors:
BOSE S
DEININGER M
GORATYBOR J
GOLDMAN JM
MELO JV
Citation: S. Bose et al., THE PRESENCE OF TYPICAL AND ATYPICAL BCR-ABL FUSION GENES IN LEUKOCYTES OF NORMAL INDIVIDUALS - BIOLOGIC SIGNIFICANCE AND IMPLICATIONS FOR THE ASSESSMENT OF MINIMAL RESIDUAL DISEASE, Blood, 92(9), 1998, pp. 3362-3367
Authors:
ROBAK T
GORATYBOR J
KRYKOWSKI E
WALEWSKI JA
BORAWSKA A
PLUZANSKA A
POTEMSKI P
HELLMANN A
ZAUCHA JM
KONOPKA L
CEGLAREK B
DURZYNSKI T
SIKORSKA A
MICHALAK K
URASINSKI J
OPALINSKA J
DMOSZYNSKA A
ADAMCZYKCIOCH MB
KURATOWSKA Z
DWILEWICZTROJACZEK J
BOGURADZKI P
DEREN M
MAJ S
GRIEB P
Citation: T. Robak et al., ACTIVITY OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) IN 2-HOUR INTRAVENOUS-INFUSION IN 94 PREVIOUSLY TREATED PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 99-105
Citation: J. Goratybor et T. Robak, DOES INTERLEUKIN-2 ENHANCE THE ANTITUMOR-ACTIVITY OF 2-CHLORODEOXYADENOSINE, The Cancer journal, 10(3), 1997, pp. 171-174
Authors:
GORATYBOR J
DEININGER M
GOLDMAN JM
MELO JV
Citation: J. Goratybor et al., THE SUSCEPTIBILITY OF CML CELLS TO FAS (CD95) MEDIATED APOPTOSIS IS INDEPENDENT OF THE ACTIVITY OF THE BCR-ABL TYROSINE KINASE, Blood, 90(10), 1997, pp. 358-358
Authors:
DEININGER WN
BOSE S
GORATYBOR J
YAN XH
GOLDMAN JM
MELO JV
Citation: Wn. Deininger et al., SELECTIVE INDUCTION OF LEUKEMIA-ASSOCIATED FUSION GENES BY HIGH-DOSE IONIZING-RADIATION, Blood, 90(10), 1997, pp. 1426-1426
Authors:
MELO JV
BOSE S
GORATYBOR J
DEININGER M
GOLDMAN JM
Citation: Jv. Melo et al., DETECTION OF LEUKEMIA-ASSOCIATED FUSION GENES IN LEUKOCYTES FROM NORMAL PEOPLE AND HEMATOPOIETIC-CELL LINES USING AN IMPROVED RT PCR ASSAY/, Blood, 90(10), 1997, pp. 2233-2233
Authors:
WARZOCHA K
KRYKOWSKI E
GORATYBOR J
FRONCZAK A
ROBAK T
Citation: K. Warzocha et al., FULMINANT 2-CHLORODEOXYADENOSINE-RELATED PERIPHERAL NEUROPATHY IN A PATIENT WITH PARANEOPLASTIC NEUROLOGICAL SYNDROME-ASSOCIATED WITH LYMPHOMA, Leukemia & lymphoma, 21(3-4), 1996, pp. 343-346
Citation: A. Szmigielska et al., INFLUENCE OF 2-CHLORODEOXYADENOSINE ALONE AND IN COMBINATION WITH CYTOSINE-ARABINOSIDE ON MURINE LEUKEMIAS L1210 AND P388, The Cancer journal, 9(6), 1996, pp. 319-322
Citation: J. Goratybor et al., THE INFLUENCE OF 2-CHLORODEOXYADENOSINE IN COMBINATION WITH TUMOR-NECROSIS-FACTOR-ALPHA OR ITS MUTEIN ON MURINE LEUKEMIAS L1210 AND P388, Mediators of inflammation, 4(3), 1995, pp. 205-208
Authors:
WARZOCHA K
GORATYBOR J
KWINKOWSKI M
SZYMANSKA B
ROBAK T
Citation: K. Warzocha et al., A COMPARISON OF THE ANTILEUKEMIC EFFECTS OF RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA AND ITS MUTEINS ON LEUKEMIA-L1210 AND LEUKEMIA P388 IN MICE, Mediators of inflammation, 3(6), 1994, pp. 411-414
Citation: T. Robak et al., THE INTERACTION OF 2-CHLORODEOXYADENOSINE (2-CDA) AND INTERFERON-ALPHA (IFN-ALPHA) ON NORMAL AND MYELOID-LEUKEMIA HEMATOPOIESIS IN-VITRO, Leukemia research, 18(4), 1994, pp. 275-281